Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Nicolas GP, Morgenstern A, Schottelius M, Fani M.
J Nucl Med. 2018 Dec 20; doi: 10.2967/jnumed.118.213496. Epub 2018 Dec 20.
Peptide Receptor Radionuclide Therapy (PRRT) is an established treatment for non-operable or metastatic neuroendocrine neoplasms that express highly and frequently somatostatin receptors. More generally, PRRT is an attractive therapy option for delivering cytotoxic radiation to tumor cells through specific...